Alternatives to Generate:Biologics

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Biotech company focused on designing and developing novel biological solutions.

Developing novel protein-based solutions for industrial and therapeutic applications.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

A frontier AI lab for biology that designs and validates antibodies and proteins.

Developing engineered biologics to harness the immune system for disease treatment.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Developing novel therapeutics for challenging diseases using advanced biological insights.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Biotechnology company focused on developing treatments for rare metabolic diseases.

AI-guided drug discovery platform for tissue-targeted medicines.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biotech company developing novel therapeutics for fibrotic diseases.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biotechnology company developing novel immunotherapies for cancer.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

A global, research-driven biopharmaceutical group focused on reproductive medicine, maternal health, and other specialized therapeutic areas.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Developing novel therapeutics for cancer by targeting the tumor microenvironment.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Global marketplace connecting researchers with human biospecimens for life science research.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

Metly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Clinical-stage company developing novel oncology therapies to overcome tumor immune evasion and drug resistance.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

VISEN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies for inflammatory and fibrotic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.